BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17266710)

  • 1. Microbiological and serological diagnosis of Lyme borreliosis.
    Wilske B; Fingerle V; Schulte-Spechtel U
    FEMS Immunol Med Microbiol; 2007 Feb; 49(1):13-21. PubMed ID: 17266710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and diagnosis of Lyme borreliosis.
    Wilske B
    Ann Med; 2005; 37(8):568-79. PubMed ID: 16338759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of lyme borreliosis in europe.
    Wilske B
    Vector Borne Zoonotic Dis; 2003; 3(4):215-27. PubMed ID: 14733674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification.
    Lebech AM
    APMIS Suppl; 2002; (105):1-40. PubMed ID: 11985118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of different Borrelia burgdorferi sensu lato strains for detection of immune response in patients with erythema migrans.
    Merljak Skocir L; Ruzić-Sabljić E; Maraspin-Carman V; Lotric-Furlan S; Logar M; Strle F
    Int J Med Microbiol; 2008 Jul; 298(5-6):493-504. PubMed ID: 17892971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of tests for detection of Borrelia burgdorferi sensu lato infection in patients with diagnosed borreliosis.
    Chmielewska-Badora J; Cisak E; Wójcik-Fatla A; Zwoliński J; Buczek A; Dutkiewicz J
    Ann Agric Environ Med; 2006; 13(2):307-11. PubMed ID: 17196006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Criteria for evaluation of immunoblots using Borrelia afzelii, Borrelia garinii and Borrelia burgdorferi sensu stricto for diagnosis of Lyme borreliosis].
    Honegr K; Havlasová J; Gebouský P; Dostál V; Pellantová V; Skrabková Z; Hulínská D
    Epidemiol Mikrobiol Imunol; 2001 Nov; 50(4):147-56. PubMed ID: 11769176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Borrelia burgdorferi sensu lato DNA by PCR in serum of patients with clinical symptoms of Lyme borreliosis.
    Santino I; Berlutti F; Pantanella F; Sessa R; del Piano M
    FEMS Microbiol Lett; 2008 Jun; 283(1):30-5. PubMed ID: 18384365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Patient with questionable Lyme borreliosis. Which laboratory parameters validate your clinical suspicion?].
    Wilske B; Fingerle V
    MMW Fortschr Med; 2002 May; 144(22):29-32. PubMed ID: 12116568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of test with antigen VlsE (C6) with tests with recombinant antigens in patients with Lyme borreliosis].
    Zajkowska JM; Kondrusik M; Pancewicz SA; Grygorczuk S; Jamiołkowski J; Stalewska J
    Pol Merkur Lekarski; 2007 Aug; 23(134):95-9. PubMed ID: 18044336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of Lyme borreliosis. How to corroborate suspected borreliosis].
    Wilske B; Fingerle V
    MMW Fortschr Med; 2000 Apr; 142(15):28-31. PubMed ID: 10842472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of decorin-binding protein A (DbpA) reveals five major groups among European Borrelia burgdorferi sensu lato strains with impact for the development of serological assays and indicates lateral gene transfer of the dbpA gene.
    Schulte-Spechtel U; Fingerle V; Goettner G; Rogge S; Wilske B
    Int J Med Microbiol; 2006 May; 296 Suppl 40():250-66. PubMed ID: 16530482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant or peptide antigens in the serology of Lyme arthritis in children.
    Heikkilä T; Huppertz HI; Seppälä I; Sillanpää H; Saxen H; Lahdenne P
    J Infect Dis; 2003 Jun; 187(12):1888-94. PubMed ID: 12792865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses to borrelial VlsE IR6 peptide variants.
    Sillanpää H; Lahdenne P; Sarvas H; Arnez M; Steere A; Peltomaa M; Seppälä I
    Int J Med Microbiol; 2007 Feb; 297(1):45-52. PubMed ID: 17234451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Western-blot with VLSE protein and "in vivo" antigens in Lyme borreliosis diagnosis].
    Zajkowska J; Kondrusik M; Pancewicz S; Grygorczuk S; Swierzbińska R; Hermanowska-Szpakowicz T; Czeczuga A; Sienkiewicz I
    Przegl Epidemiol; 2006; 60 Suppl 1():177-85. PubMed ID: 16909799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of western-immunoblotting to determine serum IgG-antibodies to antigens of different genotypes of Borrelia--Borrelia burgdorferi sensu stricto, Borrelia afzelii, and Borrelia garinii].
    Anan'eva LP; Nasonova VA; Barskova VG; Stir AS
    Med Parazitol (Mosk); 2002; (2):5-8. PubMed ID: 12214528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibodies against Borrelia garinii in diagnosis of Lyme disease].
    Flisiak R; Prokopowicz D
    Przegl Lek; 2000; 57(3):147-9. PubMed ID: 10909283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of Lyme neuroborreliosis with antibodies to recombinant proteins DbpA, BBK32, and OspC, and VlsE IR6 peptide.
    Panelius J; Lahdenne P; Saxén H; Carlsson SA; Heikkilä T; Peltomaa M; Lauhio A; Seppälä I
    J Neurol; 2003 Nov; 250(11):1318-27. PubMed ID: 14648148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genospecies and their influence on immunoblot results.
    Wilske B; Hauser U; Lehnert G; Jauris-Heipke S
    Wien Klin Wochenschr; 1998 Dec; 110(24):882-5. PubMed ID: 10048170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an internally controlled real-time PCR targeting the ospA gene for detection of Borrelia burgdorferi sensu lato DNA in cerebrospinal fluid.
    Gooskens J; Templeton KE; Claas EC; van Dam AP
    Clin Microbiol Infect; 2006 Sep; 12(9):894-900. PubMed ID: 16882295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.